SCHEMBL8673607

SCHEMBL8673607

O=C(O)CN(Cc1ccc(Cl)cc1Cl)C(=O)CCl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ SLC6A2 P23975 7/20 0.41
▸ SLC6A4 P31645 7/20 0.41
▸ ERCC1 P07992 1/20 0.40
▸ ERCC4 Q92889 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ PLAAT3 P53816 1/20 0.40
▸ PLAAT5 Q96KN8 1/20 0.40
▸ PLAAT2 Q9NWW9 1/20 0.40
▸ PLAAT4 Q9UL19 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ NR4A2 P43354 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PYCR1 P32322 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3541317 0.83 HPGD (0.50) ALDH1A1MAPK1HIF1ASLC6A2SLC6A4
SCHEMBL8672222 0.80 ALDH1A1 (0.41) ALDH1A1MAPK1HIF1ASLC6A2SLC6A4
SCHEMBL8672090 0.80 PLAAT3 (0.55) ALDH1A1SLC6A2SLC6A4HPGDPLAAT3
SCHEMBL8672261 0.77 ALDH1A1 (0.61) ALDH1A1MAPK1HIF1ASLC6A2SLC6A4
SCHEMBL8667348 0.76 NPC1 (0.53) ALDH1A1MAPK1L3MBTL1HTTNPSR1
SCHEMBL8672100 0.74 NPC1 (0.51) ALDH1A1MAPK1L3MBTL1HTTNPSR1
SCHEMBL8671700 0.72 RAB9A (0.49) ALDH1A1MAPK1HIF1AHPGDCYP2D6
SCHEMBL31107315 0.70 PYCR1 (0.51) ALDH1A1MAPK1HIF1ASLC6A2SLC6A4
SCHEMBL260512 0.70 CHRM1 (0.57) ALDH1A1MAPK1ERCC1ERCC4NR4A2
SCHEMBL29419329 0.70 CHRM1 (0.57) ALDH1A1MAPK1ERCC1ERCC4NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5834514-A INHIBITORS OF INTERLEUKIN-1B CONVERTING ENZYME, TREATMENT OF INFLAMMATORY AND IMMUNE BASED DISEASES OF THE LUNGS, CENTRAL NERVOUS SYSTEM AND CONNECTIVE TISSUES VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-11-10 — — US claimed
US-5834514-A INHIBITORS OF INTERLEUKIN-1B CONVERTING ENZYME, TREATMENT OF INFLAMMATORY AND IMMUNE BASED DISEASES OF THE LUNGS, CENTRAL NERVOUS SYSTEM AND CONNECTIVE TISSUES VERTEX PHARMACEUTICALS, INCORPORATED (US) 1998-11-10 — — US disclosed
Send feedback